Jason C. Gallagher, PharmD, FCCP, FIDP, FIDSA, BCPS

Final thoughts from experts on controlling COVID-19 and influenza.

Encouraging testing of symptomatic COVID-19 or influenza patients and utilization of available therapeutics.

The concept of the “immunization neighborhood” highlighting the importance of pharmacists in encouraging and administering vaccinations.

The importance of a rapid and accurate COVID-19 and influenza test.

The Status™ COVID-19/Flu A&B - Rapid SARS-CoV-2/Influenza A+B Antigen Panel Test: rapid testing for COVID-19, Flu A&B in one test.

Getting real time results when testing for COVID-19 and influenza.

Importance of properly diagnosing COVID-19 vs influenza to offer therapeutics.

Potential changes within office visits for COVID-19 and influenza.

Differentiating between COVID-19 and influenza.

Challenges in messaging as the understanding of COVID-19 evolves.

Several reasons patients are reluctant to getting the flu vaccine.

Promise of a dual COVID-19/influenza vaccine in development.

Slight variation in the flu vaccine from last season based on limited data.

A discussion on the lifting of COVID-19 restrictions and the potential impact on the upcoming flu season.

Panel speculates on the upcoming flu season for 2021-2022.

Multiple factors contributing to a lower-than-average flu season in 2020-2021 are discussed.

"Humans dislike change, especially when it is rapid, unexpected, or negative. Delta is all 3."

Editor-in-chief, Jason C. Gallagher, PharmD, FCCP, FIDSA, BCPS, shares how it is up to all of us in health care to evaluate the level of evidence in our practices and continue to evolve, just like the organisms we work to treat.

The drug presents a new option for patients at high risk of infections caused by organisms, such as carbapenem-resistant Enterobacteriaceae.

Contagion® editor-in-chief, Jason C. Gallagher, PharmD, FCCP, FIDSA, BCPS, affirms that the health care industry needs to hit the reset button on how antibiotics are developed.

The rise of ID pharmacy as a profession has been complementary to services uniquely offered by ID physicians, not in competition with them.

Spring has finally sprung. New guidelines for Clostridium difficile infection have been published, and the April issue of Contagion® is here with a bevy of interesting content.

New agents are in development, but none represent a magic bullet for the problems that CRE infections present.

As the ever-changing world of ID continues to evolve, so will Contagion® .

Antimicrobial stewardship and antimicrobial susceptibility testing (AST) remain critical in the race against antimicrobial resistance.

Reducing overall antibiotic exposure is likely to have an impact on decreasing antimicrobial resistance.

Jason C. Gallagher, PharmD, addresses the undetermined importance of fixed antibiotic durations.